Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer

Authors

Valerie W Rusch, Weill Cornell Medical College
G Alexander Patterson, Washington University School of Medicine in St. Louis
Salama N Waqar, Washington University School of Medicine in St. Louis
et al.

Journal

Journal of Thoracic and Cardiovascular Surgery

Publication Date

3-1-2023

Volume

165

Issue

3

First Page

828

Last Page

839.e5

Document Type

Open Access Publication

DOI

10.1016/j.jtcvs.2022.10.007

Rights and Permissions

Rusch VW, Nicholas A, Patterson GA, Waqar SN, Toloza EM, Haura EB, Raz DJ, Reckamp KL, Merritt RE, Owen DH, Finley DJ, McNamee CJ, Blasberg JD, Garon EB, Mitchell JD, Doebele RC, Baciewicz F, Nagasaka M, Pass HI, Schulze K, Johnson A, Bunn PA, Johnson BE, Kris MG, Kwiatkowski DJ, Wistuba II, Chaft JE, Carbone DP, Lee JM. Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 Mar;165(3):828-839.e5. doi: 10.1016/j.jtcvs.2022.10.007. Copyright 2022 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery. This is an open access article under the CC BY-NCND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Rusch, Valerie W; Patterson, G Alexander; Waqar, Salama N; and et al., "Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer." Journal of Thoracic and Cardiovascular Surgery. 165, 3. 828 - 839.e5. (2023).
https://digitalcommons.wustl.edu/oa_4/2708

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.